Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Pharmaust Limited ( (AU:NUZ) ) has issued an update.
Neurizon Therapeutics Limited has announced the issuance of 2,160,000 unlisted options as part of an employee incentive scheme. These securities are not intended to be quoted on the ASX, and this move is indicative of the company’s steps to enhance employee engagement and potential retention, potentially impacting its operational dynamics and stakeholder interests.
More about Pharmaust Limited
YTD Price Performance: -22.22%
Average Trading Volume: 5,745
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €36.81M
For an in-depth examination of NUZ stock, go to TipRanks’ Stock Analysis page.
